According to a new report published by Data Bridge Market Research, titled, "Africa Malaria Treatment Market," The Africa Malaria Treatment market size was valued at $ 500,416.09 Thousand in 2020, and is estimated to reach $ 817,078.98 Thousand by 2028, growing at a CAGR of 6.4% from 2021 to 2028.
Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. Furthermore, these parasites lodge into liver cells, where they multiply and grow. They then move to red blood cells to reach a stage called merozoites. These merozoites grow inside the red cells and destroy them, which further cause symptoms such as fever, tiredness, vomiting, and headache. In addition, the drugs that are used to treat and prevent malarial infections are called antimalarial. There are different types of drugs, such as quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others, available in the market for the treatment of malarial infection.
MAJOR TOC OF THE REPORT
Chapter One: Introduction
Chapter Two: Scope and Market Size
Chapter Three: Analysis and Insights
Chapter Four: Country Level Analysis
Chapter Five: Share Analysis
Chapter Six: Key player
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=
Some of the key questions answered in this report:
How has the AFRICA MALARIA TREATMENT performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the AFRICA MALARIA TREATMENT?
- What are the key regional markets?
- What are the key driving factors and challenges in the industry?
- What is the structure of the AFRICA MALARIA TREATMENT and who are the key players?
AFRICA MALARIA TREATMENT Scope and Market Size
- On the basis of agent, the Africa malaria treatment market is segmented into Plasmodium Falciparum, P. Vivax, P. Ovale, P. Malariae, and P. Knowlelsi. In 2021, the Plasmodium Falciparum segment is expected to dominate the market due to its rapid transmission. Additionally, the climate condition and humidity of Sub-Saharan Africa enhance malaria transmission by plasmodium falciparum.
- On the basis of type, the Africa malaria treatment market is segmented into medication, vaccination, and others. In 2021, the medication segment is expected to dominate the market because it is cost-effective, easily accessible, and primary treatment for the malaria patient pool.
- On the basis of treatment type, the Africa malaria treatment market is segmented into suppressive treatment and radical treatment. In 2021, the suppressive treatment segment is expected to dominate the market because it is considered the primary and fundamental treatment. Moreover, the enormous demand for suppressive treatment worldwide acts as another driving factor for market growth.
- On the basis of drug type, the Africa malaria treatment market is segmented into branded and generics. In 2021, the generics segment is expected to dominate the market because it is cost-effective compared to branded drugs. The growing demand for generics drugs from low and middle-income countries is another driving factor for market growth.
- On the basis of route of administration, the Africa malaria treatment market is segmented into oral and parenteral. In 2021, the oral segment is expected to dominate the market because it is considered to be the first line of therapy. Moreover, the low manufacturing cost of tablets, capsules, and other orally administered drugs act as another driving factor for the market growth.
- On the basis of end user, the Africa malaria treatment market is segmented into hospitals, specialty clinics, home healthcare, and others. In 2021, the hospitals segment is expected to dominate the market because of the increased healthcare expenditure by hospitals on advanced medical treatment.
- On the basis of distribution channel, the Africa malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. In 2021, the direct tender segment is expected to dominate the market because of the surge in innovations and technologies, and the rising government funding is also propelling the market's growth.
Get the Free sample copy of the report here:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=africa-malaria-treatment-market
Market Analysis and Insights: AFRICA MALARIA TREATMENT
- Data Bridge Market Research analyses that the market is growing with a CAGR of 6.46.4% in the forecast period of 2021 to 2028 and is expected to reach USD 817,078.98 thousand by 2028 from USD 500,416.09 thousand in 2020
AFRICA MALARIA TREATMENT - Regional Level Analysis
- The countries covered in the Africa malaria treatment market report are Nigeria, Democratic Republic of Congo, Uganda, Coste D’ Ivoire, Niger, Kenya, Egypt, South Africa, and the Rest of Africa. In the Africa malaria treatment market, Nigeria is expected to grow with the most promising growth due to the rapidly increasing patients and advancements in technology.
AFRICA MALARIA TREATMENT - Share Analysis:
- The Africa malaria treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Africa malaria treatment market.
Key player - AFRICA MALARIA TREATMENT
- Some major players operating in the Africa malaria treatment market are Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Cipla Inc., GlaxoSmithKline plc., Bliss GVS Pharma Ltd., MMV, Novartis AG, Taj Pharmaceuticals Limited, Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited), AJANTA PHARMA, Strides Pharma Science Limited, sanofi-aventis U.S. LLC (A Subsidiary of Sanofi), Viatris Inc., among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Get Full Access of Report@
https://www.databridgemarketresearch.com/reports/africa-malaria-treatment-market
Top Trending Reports:
Paroxysmal Choreoathetosis Market
Diabetic Hyperosmolar Syndrome Market
Obstructive Hydrocephalus Market
Autoimmune gastrointestinal dysmotility market
Pharmaceutical Excipients Market
Europe Pharmaceutical Excipients Market
Asia-Pacific Pharmaceutical Excipients Market
Middle East and Africa Pharmaceutical Excipients Market
North America Pharmaceutical Excipients Market
North America Malaria Treatment Market
Middle East and Africa Malaria Treatment Market
Asia-Pacific Malaria Treatment Market
Europe Malaria Treatment Market
Asia-Pacific Microalgae Market
Middle East and Africa Microalgae Market
North America Microalgae Market
Isobutyryl-Coa Dehydrogenase Deficiency Treatment Market
Foodborne trematodiases disease market
Coronary Artery Disease Market
Optic nerve atrophy Treatment Market
Venous Reflux Disease Treatment Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-386.8-2818
Email: [email protected]
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek